Each dot is one of the 6 Dental stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 8.2% and the median P/E 23.89.
Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.
| # | Industry | ||||
|---|---|---|---|---|---|
| 1 | RMDResmed | 9.9% | 24.11 | $36.72B | Medical Devices |
| 2 | SOLVSolventum | -0.9% | 10.37 | $14.87B | Medical Devices |
| 3 | ALGNAlign Technology | 4.4% | 26.19 | $10.83B | Dental |
| 4 | HSICHenry Schein | 6.5% | 23.68 | $9.54B | Drug Distribution |
| 5 | NVSTEnvista Holdings | 11.9% | 39.99 | $3.80B | Dental |
| 6 | PDEXPro Dex | 16.4% | 14.52 | $198.34M | Medical Devices |
Among Dental stocks, the largest companies growing revenue faster than the median (8.2%) while trading below the median P/E (23.89) are Pro Dex (PDEX). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.
The largest companies with a P/E above the median and revenue growth below it are Align Technology (ALGN).
The median P/E across the 6 Dental stocks plotted is 23.89, with the middle half between 16.81 and 25.67.
The median is 8.2%, with the middle half between 4.9% and 11.4%.
The rank correlation (Spearman) is 0.26, a weak positive relationship: companies with a higher Revenue Growth (1y) (TTM) tend to have a higher P/E.
A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.
Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.